ArticleFrontiers in pharmacology2020

Inhibition of the STAT3 Signaling Pathway Contributes to the Anti-Melanoma Activities of Shikonin.

Hui-Hui Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.